About Christopher

Christopher has been a board member at MassBioEd since 2014 and is the Chief Executive Officer at Akron Bio. Prior, he was Vice President and General Manager of Viral Vector Services in Thermo Fisher Scientific’s Pharma Services Group.  He transitioned into this role when Thermo Fisher acquired Brammer Bio, where he served as chief operating officer. Christopher has more than 30 years of experience in biopharmaceutical manufacturing, process development, plant operations, and quality system implementation.  Prior to joining Brammer Bio, he served as general manager for the Sanofi-Genzyme Allston Landing site overseeing operations and leading an integrated remediation program associated with the consent decree. Christopher has led gene therapy operations and recombinant protein manufacturing at Genzyme and Bioreliance and he began his career in viral vaccine development at American Cyanamid/Wyeth (now Pfizer) in Pearl River, NY. He has a M.S. in biochemistry at New York Medical College, and his B.S. in biology at Rutgers University.